Wellington Management Group LLP Buys Shares of 192,125 LivaNova PLC (NASDAQ:LIVN)

Wellington Management Group LLP purchased a new position in shares of LivaNova PLC (NASDAQ:LIVN - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 192,125 shares of the company's stock, valued at approximately $8,897,000. Wellington Management Group LLP owned 0.35% of LivaNova as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in the business. Xponance Inc. boosted its stake in LivaNova by 6.1% in the 4th quarter. Xponance Inc. now owns 7,762 shares of the company's stock worth $359,000 after buying an additional 445 shares during the last quarter. Swiss National Bank boosted its position in shares of LivaNova by 0.7% in the fourth quarter. Swiss National Bank now owns 106,819 shares of the company's stock worth $4,947,000 after acquiring an additional 700 shares during the last quarter. Central Pacific Bank Trust Division increased its position in LivaNova by 21.2% during the fourth quarter. Central Pacific Bank Trust Division now owns 4,117 shares of the company's stock worth $191,000 after purchasing an additional 720 shares during the last quarter. Amalgamated Bank raised its stake in LivaNova by 3.0% during the fourth quarter. Amalgamated Bank now owns 24,900 shares of the company's stock worth $1,153,000 after purchasing an additional 729 shares during the period. Finally, Rhumbline Advisers raised its stake in LivaNova by 0.5% during the fourth quarter. Rhumbline Advisers now owns 177,938 shares of the company's stock worth $8,240,000 after purchasing an additional 899 shares during the period. Institutional investors and hedge funds own 97.64% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the company. Needham & Company LLC reaffirmed a "buy" rating and issued a $64.00 target price on shares of LivaNova in a research report on Monday, March 17th. Barclays reduced their price objective on LivaNova from $58.00 to $56.00 and set an "equal weight" rating on the stock in a research note on Friday, March 7th. The Goldman Sachs Group dropped their target price on shares of LivaNova from $64.00 to $55.00 and set a "buy" rating for the company in a research report on Monday, March 3rd. Wolfe Research cut shares of LivaNova from an "outperform" rating to a "peer perform" rating in a research report on Wednesday, February 26th. Finally, Mizuho dropped their price objective on shares of LivaNova from $70.00 to $60.00 and set an "outperform" rating for the company in a research report on Wednesday, February 26th. Two equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Buy" and a consensus price target of $61.17.

LivaNova Stock Up 0.7 %

Shares of NASDAQ LIVN traded up $0.23 during midday trading on Tuesday, reaching $35.69. 88,012 shares of the company's stock were exchanged, compared to its average volume of 624,842. The business's fifty day moving average price is $41.10 and its two-hundred day moving average price is $47.17. LivaNova PLC has a 52-week low of $32.48 and a 52-week high of $64.48. The stock has a market capitalization of $1.94 billion, a PE ratio of 85.06 and a beta of 0.90. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.87 and a current ratio of 3.37.

LivaNova Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.